Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Corcept Therapeutics (CORT) over the last 8 years, with Q3 2025 value amounting to $923.3 million.

  • Corcept Therapeutics' Treasury Shares rose 3534.46% to $923.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $923.3 million, marking a year-over-year increase of 3534.46%. This contributed to the annual value of $696.2 million for FY2024, which is 962.01% up from last year.
  • Per Corcept Therapeutics' latest filing, its Treasury Shares stood at $36.0 million for Q3 2025, which was up 1036511.63% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Treasury Shares registered a high of $36.0 million during Q3 2025, and its lowest value of $20000.0 during Q1 2024.
  • In the last 5 years, Corcept Therapeutics' Treasury Shares had a median value of $1.3 million in 2021 and averaged $9.0 million.
  • In the last 5 years, Corcept Therapeutics' Treasury Shares surged by 44147.5% in 2021 and then surged by 597.47% in 2024.
  • Over the past 5 years, Corcept Therapeutics' Treasury Shares (Quarter) stood at $410.4 million in 2021, then rose by 11.14% to $456.1 million in 2022, then skyrocketed by 39.23% to $635.1 million in 2023, then rose by 9.62% to $696.2 million in 2024, then skyrocketed by 32.62% to $923.3 million in 2025.
  • Its Treasury Shares stands at $923.3 million for Q3 2025, versus $866.9 million for Q2 2025 and $744.7 million for Q1 2025.